Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer
Liqun Yu(Baylor College of Medicine), Xiang H.-F. Zhang(Baylor College of Medicine), Yichao Shen(Baylor College of Medicine), Sergio Aguirre(Baylor College of Medicine), Hilda L. Chan(Baylor College of Medicine), Yang Gao(Baylor College of Medicine), Bradley C. Pingel(Baylor College of Medicine), Yunfeng Ding(Baylor College of Medicine), Lívia S. Eberlin(Baylor College of Medicine), Luis Becerra-Dominguez(Baylor College of Medicine), Philip L. Lorenzi(City Of Hope National Medical Center), Igor Bado(Tisch Hospital), Bo Wei(Shanghai Changzheng Hospital), Zhan Xu(Baylor College of Medicine), Charlotte Helena Rivas(Baylor College of Medicine), Xiaoxin Hao(Baylor College of Medicine), Keziah Liebenberg(Baylor College of Medicine), Jun Liu(Sichuan University), Weijie Zhang(Nanjing Medical University), Ling Wu(Baylor College of Medicine), Yi-Hsuan Wu(Baylor College of Medicine), Fengshuo Liu(Baylor College of Medicine), David G. Edwards(University of Delaware)
Cited by 59
Related Papers
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
|Proceedings of the National Academy of Sciences|2013|833